endogenous glp-1 Mechanism of action of agonists – My Endo Consult GLP-1 and the kidney: from

J Clin Invest 2023;133:e157515.ArticlePubMedPMC 75

The aim of this narrative review is to integrate evidence from transcriptomics, GPCR signaling, GLP-1RA pharmacokinetics, -arrestin biology, and pharmacovigilance data to identify critical gaps and to propose a hypothesis-driven framework for semaglutide-associated oral and salivary dysfunction

For daily injectable GLP-1 medications : Liraglutide (Victoza/Saxenda) : If you miss a daily dose, resume your regular dosing schedule with the next scheduled dose

What this suggests is that the hormonal improvement observed may not be explained solely by weight loss

The answers to these questions, and many more, are yet to be determined but will be crucial to the future of what patient access will look like for these products